Constellation Brands
STZ
$120.98
-5.62%
Constellation Brands, Inc. is a leading producer and marketer of beer, wine, and spirits, with its portfolio anchored by iconic Mexican beer brands such as Modelo and Corona, which generate over 90% of its revenue in the U.S. market. As the largest alcoholic beverage provider in the U.S. by beer volume, the company holds a dominant competitive position in the high-growth imported beer segment, while also maintaining a smaller wine and spirits business that has been strategically pruned in recent years. The current investor narrative centers on the company's ability to sustain beer volume growth and margin expansion amid a challenging consumer environment, with recent headlines highlighting strong beer sales and aggressive share buybacks that have masked a broader stock slump, as well as concerns over future profit guidance that missed Wall Street expectations in the latest earnings report.…
STZ
Constellation Brands
$120.98
Related headlines
Investment Opinion: Should I buy STZ Today?
Based on the data, STZ is rated a 'Buy' with a target price of $170.83, implying 33% upside from the current price of $128.18. The thesis is that the company's dominant beer portfolio and margin expansion will drive EPS growth to $15.10, justifying the low forward PE of 10.3x. The stock is undervalued relative to its historical PE and peers, offering a favorable risk/reward for patient investors.
Sign up to view all
STZ 12-Month Price Forecast
The AI assessment is neutral with medium confidence. While the valuation is attractive and margins are improving, the recent revenue decline and negative price momentum create uncertainty. The stock's fate hinges on beer volume trends; if volumes stabilize, the low forward PE could drive a re-rating, but continued declines could push the stock lower. Monitoring quarterly beer shipment data and management guidance will be key to adjusting the stance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Constellation Brands's 12-month outlook, with a consensus price target around $170.83 and implied upside of +41.2% versus the current price.
Average Target
$170.83
0 analysts
Implied Upside
+41.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$115 - $209
Analyst target range
The analyst price targets range from a low of $115.00 to a high of $209.00, with the high target suggesting a potential 63% upside, likely assuming a successful turnaround in beer volume growth and margin expansion, while the low target implies a 10% downside, possibly reflecting concerns about continued volume declines and competitive pressures. The wide spread of $94 between the low and high targets indicates high uncertainty about the company's future performance, which is typical for a stock undergoing a transition. Recent ratings actions have been largely neutral, with no major upgrades or downgrades in the last few months, suggesting that analysts are waiting for clearer signs of stabilization before adjusting their outlooks.
Drowning in data?
Find the real signal!
Bulls vs Bears: STZ Investment Factors
Constellation Brands presents a mixed picture: strong brand portfolio and margin expansion are offset by recent revenue declines and a persistent stock downtrend. The bull case rests on the forward PE of 10.3x and analyst targets implying 33% upside, while the bear case is anchored by the 3.3% revenue drop and high debt. Currently, the bearish technicals and revenue weakness outweigh the valuation appeal, but the margin expansion and buybacks provide a floor. The key tension is whether the company can return to volume growth—if beer volumes stabilize, the stock could re-rate higher; if not, further downside toward the 52-week low is possible.
Bullish
- Dominant imported beer franchise: Constellation's Modelo and Corona brands hold the #1 and #2 positions in U.S. imported beer, with over 90% of revenue from this high-growth segment. The company's scale and brand equity provide a durable competitive moat that supports pricing power and volume resilience.
- Expanding gross margins: Gross margin expanded to 54.3% in Q1 FY2027 from 50.8% a year ago, driven by improved pricing and cost management. This margin expansion is a key driver of the expected EPS growth, supporting the forward PE of 10.3x.
- Attractive forward valuation: With a forward PE of 10.3x versus a trailing PE of 16.4x, the market is pricing in significant earnings growth. Analysts estimate EPS of $15.10 for the current fiscal year, implying a 59% increase, which appears achievable given margin trends and cost controls.
- Strong free cash flow and buybacks: TTM free cash flow stands at $1.83 billion, providing ample capacity for share repurchases and dividends. Aggressive buybacks have reduced share count, supporting per-share earnings growth even amid flat revenue.
Bearish
- Revenue decline in latest quarter: Q1 FY2027 revenue fell 3.3% YoY to $2.43 billion, with beer down 4.0% and wine/spirits down 12.6%. This marks a break from prior growth and signals weakening consumer demand and competitive pressures.
- Stock in clear downtrend: STZ has declined 12.1% over the past year, underperforming the S&P 500 by 30.8 percentage points. Trading near its 52-week low of $126.45, the stock shows persistent bearish momentum and negative relative strength.
- High debt levels: Debt-to-equity is 1.39, indicating significant leverage. Interest expenses of $85.8 million in Q1 FY2027 consume a notable portion of operating income, increasing financial risk if cash flows weaken.
- Disappointing guidance: Despite beating Q4 estimates, the stock fell due to future profit guidance that missed Wall Street expectations. This suggests management's outlook is cautious, and the market is skeptical of near-term growth.
STZ Technical Analysis
Constellation Brands is in a clear downtrend, with the stock price declining 12.1% over the past year and currently trading at $128.18, which is near the bottom of its 52-week range (76% of the range, calculated as (128.18 - 126.45) / (168.60 - 126.45)). This positioning near the 52-week low of $126.45 suggests that the market is pricing in significant negative sentiment, and the stock is testing key support levels that could either offer a value opportunity or signal further downside if broken. The 1-year price change of -12.1% contrasts sharply with the S&P 500's +18.65% gain, indicating severe underperformance and a persistent bearish trend.
Beta
0.40
0.40x market volatility
Max Drawdown
-30.2%
Largest decline past year
52-Week Range
$120-$169
Price range past year
Annual Return
-17.2%
Cumulative gain past year
| Period | STZ Return | S&P 500 |
|---|---|---|
| 1m | -10.9% | -0.9% |
| 3m | -15.0% | +5.6% |
| 6m | -18.4% | +15.0% |
| 1y | -17.2% | +18.1% |
| ytd | -14.3% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
STZ Fundamental Analysis
In the most recent quarter (Q1 FY2027, ended May 31, 2026), Constellation Brands reported revenue of $2.43 billion, a decline of 3.3% year-over-year, breaking a streak of modest growth seen in prior quarters (Q2 FY2026 revenue was $2.48 billion, up from $2.92 billion in Q2 FY2025, though that quarter included a large impairment). The revenue decline was driven by a 4.0% drop in the beer segment (to $2.28 billion) and a 12.6% decline in wine and spirits (to $149 million), reflecting broader industry softness and strategic divestitures. Despite the top-line contraction, the company's gross margin expanded to 54.3% in Q1 FY2027, up from 50.8% in the year-ago quarter, indicating improved pricing and cost management, though the multi-quarter trend shows some volatility (gross margins ranged from 49.6% to 54.3% over the last four quarters).
Quarterly Revenue
$2.4B
2026-05
Revenue YoY Growth
-3.3%
YoY Comparison
Gross Margin
54.3%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is STZ Overvalued?
Given that Constellation Brands is profitable, the price-to-earnings (PE) ratio is the most appropriate valuation metric. The trailing PE stands at 16.4x, while the forward PE is 10.3x, implying that the market expects significant earnings growth (approximately 59% EPS growth) over the next year, which is supported by analyst estimates of $15.10 EPS for the current fiscal year. This gap between trailing and forward multiples suggests that the market is pricing in a strong recovery in profitability, likely driven by margin expansion and cost controls, despite the recent revenue decline.
PE
16.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 9x~46x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant: debt-to-equity of 1.39 and interest expenses of $85.8 million per quarter create vulnerability to rising rates or cash flow shortfalls. The current ratio of 1.08 is tight, indicating potential liquidity pressure. Revenue concentration in beer (over 90% of revenue) means any volume decline in Modelo/Corona directly impacts earnings. The recent 3.3% revenue decline and negative EPS in prior quarters (e.g., -$6.59 in Q2 FY2025) highlight earnings volatility, though the latest quarter showed a net margin of 26.9%.
